Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1986 1
1989 1
1994 1
1995 1
1996 4
1997 4
1998 2
1999 2
2003 1
2006 1
2008 2
2009 3
2010 4
2011 5
2012 9
2013 7
2014 9
2015 6
2016 10
2017 11
2018 13
2019 12
2020 9
2021 11
2022 5
2023 5
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Results by year

Filters applied: . Clear all
Page 1
Hand, foot, and mouth disease in pregnancy: 7 years Tuscan experience and literature review.
Giachè S, Borchi B, Zammarchi L, Colao MG, Ciccone N, Sterrantino G, Rossolini GM, Bartoloni A, Trotta M. Giachè S, et al. Among authors: sterrantino g. J Matern Fetal Neonatal Med. 2021 May;34(9):1494-1500. doi: 10.1080/14767058.2019.1638898. Epub 2019 Jul 10. J Matern Fetal Neonatal Med. 2021. PMID: 31291796 Free article. Review.
Prevalence and Phenotypic Susceptibility to Doravirine of the HIV-1 Reverse Transcriptase V106I Polymorphism in B and Non-B Subtypes.
Giammarino F, de Salazar A, Malet I, Viñuela L, Fuentes A, Saladini F, Bartolini N, Charpentier C, Lambert-Niclot S, Sterrantino G, Colao MG, Micheli V, Bertoli A, Fabeni L, Teyssou E, Delgado R, Falces-Romero I, Aguilera A, Gomes P, Paraskevis D, Santoro MM, Ceccherini-Silberstein F, Marcelin AG, Moreno C, Zazzi M, García F. Giammarino F, et al. Among authors: sterrantino g. J Infect Dis. 2024 Jun 14;229(6):1796-1802. doi: 10.1093/infdis/jiae010. J Infect Dis. 2024. PMID: 38206187
Comparing the efficacy and safety of a first-line regimen with emtricitabine/tenofovir alafenamide fumarate plus either bictegravir or dolutegravir: Results from clinical practice.
Ciccullo A, Baldin G, Borghi V, Oreni L, Lagi F, Fusco P, Giacomelli A, Torti C, Sterrantino G, Mussini C, Antinori S, Di Giambenedetto S. Ciccullo A, et al. Among authors: sterrantino g. Int J Antimicrob Agents. 2024 Jan;63(1):107040. doi: 10.1016/j.ijantimicag.2023.107040. Epub 2023 Nov 20. Int J Antimicrob Agents. 2024. PMID: 37981074
Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients.
Fabbiani M, Masini M, Rossetti B, Ciccullo A, Borghi V, Lagi F, Capetti A, Colafigli M, Panza F, Baldin G, Mussini C, Sterrantino G, Farinacci D, Montagnani F, Tumbarello M, Di Giambenedetto S. Fabbiani M, et al. Among authors: sterrantino g. Viruses. 2023 May 8;15(5):1123. doi: 10.3390/v15051123. Viruses. 2023. PMID: 37243208 Free PMC article.
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients.
Nannini G, Di Gloria L, Russo E, Sterrantino G, Kiros ST, Coppi M, Niccolai E, Baldi S, Ramazzotti M, Di Pilato V, Lagi F, Bartolucci G, Rossolini GM, Bartoloni A, Amedei A. Nannini G, et al. Among authors: sterrantino g. Microbes Infect. 2024 Jul-Aug;26(5-6):105339. doi: 10.1016/j.micinf.2024.105339. Epub 2024 Apr 16. Microbes Infect. 2024. PMID: 38636822 Free article.
Morning dosing for dolutegravir-related insomnia and sleep disorders.
Capetti AF, Di Giambenedetto S, Latini A, Sterrantino G, De Benedetto I, Cossu MV, Gori A. Capetti AF, et al. Among authors: sterrantino g. HIV Med. 2018 May;19(5):e62-e63. doi: 10.1111/hiv.12540. Epub 2017 Aug 1. HIV Med. 2018. PMID: 28762661 Free article. No abstract available.
Shall We Dance? Extending TANGO's Results to Clinical Practice.
Borghetti A, Ciccullo A, Baldin G, Rusconi S, Capetti A, Sterrantino G, Gennari W, Mussini C, Borghi V, Di Giambenedetto S. Borghetti A, et al. Among authors: sterrantino g. Clin Infect Dis. 2020 Oct 23;71(7):e200-e201. doi: 10.1093/cid/ciaa313. Clin Infect Dis. 2020. PMID: 32198516 Free PMC article. No abstract available.
Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian Cohort.
Ciccullo A, Baldin G, Borghi V, Lagi F, Latini A, d'Ettorre G, Oreni L, Fusco P, Capetti A, Fabbiani M, Giacomelli A, Grimaldi A, Madeddu G, Sterrantino G, Mussini C, Di Giambenedetto S. Ciccullo A, et al. Among authors: sterrantino g. Viruses. 2022 Jan 17;14(1):163. doi: 10.3390/v14010163. Viruses. 2022. PMID: 35062367 Free PMC article.
Comparing the long-term effectiveness and safety of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide fumarate as first-line regimens: a real life multicentre cohort.
Ciccullo A, Baldin G, Cervo A, Moschese D, Lagi F, Cossu MV, Grimaldi A, Giacomelli A, Rusconi S, Sterrantino G, Borghetti A, Antinori S, Mussini C, Di Giambenedetto S. Ciccullo A, et al. Among authors: sterrantino g. J Antimicrob Chemother. 2024 Oct 30:dkae392. doi: 10.1093/jac/dkae392. Online ahead of print. J Antimicrob Chemother. 2024. PMID: 39478330
127 results